DataMEDS AI, Inc. (MEDS) stock score
$2.96 ▼ -12.94% today
DataMEDS AI, Inc. (MEDS) is a Medical Distribution company in the Healthcare sector, listed in the United States. On DadFin's weekly run it scores 23.2 out of 100 on the Dad Score, a weak reading that places the business ahead of 23% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #708 of 974. Its strongest axes are price action, risk and liquidity; its weakest are valuation and quality.
Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →
The eight axes
Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.
Key numbers
What subscribers see on MEDS
- Value Score: is the price right for this business, the score the Value book is selected on.
- Trader Score: is it set up to move, refreshed every 15 minutes in the session.
- The full eight-axis breakdown, every input and its percentile.
- SEC filings, insider buying, earnings history and peers side by side.
- Whether it is in this week's published books, with the receipts.
Medical Distribution peers
| Stock | Company | Dad Score | Band |
|---|---|---|---|
| MCK | McKesson Corporation | 92.1 | strong |
| COR | Cencora, Inc. | 70.0 | good |
| CAH | Cardinal Health, Inc. | 97.0 | strong |
| HSIC | Henry Schein, Inc. | 82.6 | good |
Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.